Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma of the Gastroesophageal Junction

Explore clinical trials studying Adenocarcinoma of the Gastroesophageal Junction. Study availability and eligibility vary by location and protocol.

36 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma of the Gastroesophageal Junction trial results

Completed

Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

NCT01231399

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, +18 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • South Pasadena Cancer Center South Pasadena, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View Trial Details
Completed

Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction

NCT00757172

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Digestive System Diseases, +9 more
Locations
  • Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah, Georgia, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Evanston Hospital Evanston, Illinois, United States
View all 21 locations
View Trial Details
Completed

Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer

NCT00982592

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Digestive System Diseases, +12 more
Locations
  • University of California at Davis Cancer Center Sacramento, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Cancer Care Center of Decatur Decatur, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View all 30 locations
View Trial Details
Completed

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

NCT01260701

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Gastric Adenocarcinoma, Digestive System Diseases, +10 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 187 locations
View Trial Details
Completed

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

NCT01640782

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach
Locations
  • ASL 6 - Fabriano Fabriano, Ancona, Italy
  • Ospedale Civile di Senigallia Senigallia, Ancona, Italy
  • dell'Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I Torrette Di Ancona, Ancona, Italy
  • Ospedale. S. Donato Arezzo, Italy
View all 101 locations
View Trial Details
Completed

Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery

NCT00991952

Conditions
Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Digestive System Diseases, +14 more
Locations
  • City of Hope Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details

Related conditions